THIOTHIXENE
ANTIPSYCHOTICS · SCHIZOPHRENIA
GSMS, INC.
Drug class
Thioxanthenes
Thioxanthenes are a chemical class of first-generation, conventional antipsychotic medications that are structurally related to phenothiazines, distinguished by a carbon-linked side chain replacing the nitrogen in the central tricyclic ring. Read more about Thioxanthenes
3 drugs in this class 3 manufacturers
Drugs in Thioxanthenes
THIOTHIXENE
ANTIPSYCHOTICS · SCHIZOPHRENIA
Amneal Pharmaceuticals
THIOTHIXENE
ANTIPSYCHOTICS · SCHIZOPHRENIA
NOVITIUM/ANI PH
Filter & compare in the drug finder →
Opens the drug finder with Thioxanthenes preselected. Add indication or manufacturer filters there.
Thioxanthenes are a chemical class of first-generation, conventional antipsychotic medications that are structurally related to phenothiazines, distinguished by a carbon-linked side chain replacing the nitrogen in the central tricyclic ring.
They exert their therapeutic effects primarily by acting as competitive antagonists at postsynaptic dopamine D2 receptors in the central nervous system, thereby dampening excessive dopaminergic neurotransmission in subcortical pathways.
Clinically, members of this class—such as thiothixene—are primarily indicated for the management of schizophrenia and other acute or chronic psychotic disorders.
-
fda.gov
Thioxanthenes are a chemical class of first-generation, conventional antipsychotic medications that are structurally related to phenothiazines, distinguished by a carbon-linked side chain replacing the nitrogen in the central tricyclic ring Clinically, members of this class—such as thiothixene—are primarily indicated for the management of schizophrenia and other acute or chronic psychotic disorders
-
nih.gov
Thioxanthenes are a chemical class of first-generation, conventional antipsychotic medications that are structurally related to phenothiazines, distinguished by a carbon-linked side chain replacing the nitrogen in the central tricyclic ring They exert their therapeutic effects primarily by acting as competitive antagonists at postsynaptic dopamine D2 receptors in the central nervous system, thereby dampening excessive dopaminergic neurotransmission in subcortical pathways Clinically, members of ...
-
patsnap.com
They exert their therapeutic effects primarily by acting as competitive antagonists at postsynaptic dopamine D2 receptors in the central nervous system, thereby dampening excessive dopaminergic neurotransmission in subcortical pathways
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.